TGen Finds Therapeutic Targets for Rare Cancer in Children 06 September 2010 RNAi screening used for the first time to study Ewing’s sarcoma.
Finding Variants in the Human Genome 06 September 2010 HapMap 3 points the way forward for human genetics studies; results reported in Nature.
Sigma® Life Science Enters Genetically Modified Cell Market 06 September 2010 Sigma Life Science launches range of engineered cell lines exploiting CompoZr® zinc finger nuclease technology.
EMBL Scientists Uncover Counterpart of Cerebral Cortex in Marine Worms 03 September 2010 Findings give an idea of what the most ancient higher brain centres looked like, and what our distant ancestors used them for.
Microsoft Excel-based Algorithm Predicts Cancer Prognosis 01 September 2010 The algorithm will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training.
RecipharmCobra Biologics Announces Patent for Novel Antibiotic-Free Plasmid Maintenance System 01 September 2010 oriSELECT plasmid maintenance system wins US and European patents.
Alnylam and Collaborators Publish new Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene 31 August 2010 New Research shows silencing of alpha-synuclein in the Substantia Nigra of non-human primates with an RNAi therapeutic.
First Genetic Link to Common Migraine Exposed 31 August 2010 Genetic variant may increase susceptibility to migraine triggers.
Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions 31 August 2010 Lonza expands its custom service platform to viral vaccines and gene therapy vectors.